Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    Constantine Mavroudis, Carl Lewis Backer, editors ; illustrations by Rachid F. Idriss.
    Contents:
    Cannulation Techniques
    Palliation Techniques
    Patent Ductus Arteriosus
    Vascular Rings, Tracheoplasty and Pulmonary Artery Sling
    Coarctation of the Aorta/ Interrupted Aortic Arch
    Interrupted Aortic Arch Repair, Type B
    Atrial Septal Defect, PAPVR, and Scimitar
    Ventricular Septal
    Atrioventricular Canal Defect
    Truncus Arteriosus
    Aortopulmonary Window
    Tetralogy of Fallot
    Pulmonary Atresia with VSD
    Double Outlet Ventricles
    Transposition of the Great Arteries
    Congenitally Corrected Transposition of the Great Arteries
    Bidirectional Glenn and Fontan Operations
    Fontan Revision and Arrhythmia Surgery
    Arrhythmia Surgery
    Ebstein?s Anomaly
    Left Ventricular Outflow Tract Obstruction
    Norwood Operation
    Aortic-Left Ventricular Tunnel
    Mitral Valve Repairs
    Total Anomalous Pulmonary Venous Repair
    Cor Triatriatum
    Sinus of Valsalva Aneurysm
    Coronary Artery Anomalies
    Cardiac Transplantation
    Selected Complications.
    Digital Access Springer 2015
  • Article
    Deykin D.
    Drugs. 1977 Jan;13(1):46-51.
    Heparin remains the most effective antithrombotic drug. It acts by combining with plasma antithrombin, thereby accelerating the neurtalisation of thrombin and other acitvated coagulation factors. Full-dose intravenous heparin is indicated in all cases of pulmonary embolism and established deep venous thrombosis, unless there exist compelling contraindications. Continuous intravenous infusion of heparin appears to be safer than intermittent injection. Low-dose subcutaneous heparin is effective in preventing the initial occurrence of thigh vein thrombi and in reducing the incidence of fatal pulmonary embolism in general surgical patients over the age of 40. The efficacy of low-dose heparin in preventing pulmonary emboli following hip surgery has not been established. The incidence of severe heparin-induced thrombocytopenia appears to be rising. Platelet counts should be performed in all patients receiving heparin by any mode of administration.
    Digital Access Access Options
doi:10.1007/978-1-4471-5319-1 doi:10.2165/00003495-197713010-00005